The Pharma Data
OCTOBER 18, 2020
Synairgen reported positive results from its Phase II trial of SNG001 in 101 hospitalized COVID-19 patients in July 2020, indicating that its inhaled IFN-beta could provide a valuable treatment option in the face of the global COVID-19 pandemic. For more information, please visit www.akronbiotech.com. About Synairgen.
XTalks
FEBRUARY 4, 2021
Biobanks are used for the coordination of high-yield patient sample collection. Moreover, biobanks are no longer passive biorepositories for accrual of samples and serve a more utilitarian function in identifying and coordinating specific research cohorts for longitudinal and prospective studies. Biobanking Models.
Advarra
FEBRUARY 13, 2024
Having a singular password could also potentially affect trial timelines. Since staff would temporarily be unable to properly access the necessary systems, it could lead to wasted time and trial delays. SSO also has the ability to enhance user accountability and compliance within an organization.
Expert insights. Personalized for you.
52 
Let's personalize your content